http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009173594-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-12 |
filingDate | 2008-01-25^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_573cc96ec0c0405efd041d4d38fab89e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb0b29b23a275db272d1ea964d4577e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2770c1f65870ce72b68a5364a2b5c9ed |
publicationDate | 2009-08-06^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2009173594-A |
titleOfInvention | Pharmaceutical composition for inhibiting accumulation of amyloid β protein |
abstract | Disclosed is a compound that suppresses the accumulation of amyloid β protein. The present invention relates to a pharmaceutical composition for inhibiting the accumulation of amyloid β protein comprising a compound represented by formula (I) or the like, or a pharmaceutically acceptable salt thereof; An amyloid β protein accumulation inhibitor containing a compound represented by formula (I), or a pharmaceutically acceptable salt thereof; a compound represented by formula (I) or the like, or a pharmaceutically acceptable salt thereof, Use for inhibiting accumulation of amyloid β protein; a compound represented by formula (I) or the like, or a pharmaceutically acceptable salt thereof, is effective for mammals that can be diagnosed with amyloid β protein-related diseases Provided is a method for suppressing accumulation of amyloid β protein having a step of administering an amount. [Selection] Figure 1 |
priorityDate | 2008-01-25^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 341 of 341.